PGM
STIM icon

Parian Global Management’s Neuronetics STIM Stock Holding History

Parian Global Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$892K – 24
2021
Q4 		$892K Hold
200,000
– – 0.72% 28
2021
Q3 		$2.47M Buy
+200,000
New +$1.92M 1.73% 20

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Parian Global Management's STIM Position: Q3 2022 in Review

Parian Global Management increased its Neuronetics (STIM) stake by 16% in Q3 2022, buying an estimated $408K and bringing the position to 830,273 shares worth $2.64M. The position accounts for 8.59% of the portfolio, ranked #4.

Parian Global Management first reported a position in STIM in Q1 2021 and has held it in 7 quarters since. The position peaked at $14M in Q1 2021. 76 funds tracked by Wall St. Rank hold STIM as of Q3 2022.

  • Parian Global Management held 830,273 shares of Neuronetics worth $2.64M as of Q3 2022.
  • Parian Global Management bought 112,300 Neuronetics shares in Q3 2022, an estimated $408K.
  • Neuronetics made up 8.59% of Parian Global Management's portfolio in Q3 2022, its #4 holding.
  • Parian Global Management first reported a position in Neuronetics in Q1 2021 and has held it in 7 quarters since.
  • Parian Global Management's Neuronetics position peaked at $14M in Q1 2021.
  • 76 funds tracked by Wall St. Rank held Neuronetics as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.